Flora Health

Overview

Flora Health is an EHR systems integrator for pharma HCP engagement, connecting brand activation and access-strategy workflows directly inside existing EHR and health-system environments. Flora is best read as a workflow-native point-of-care channel, not as a full-service marketing agency, a medical-affairs platform, or an outsourced field-deployment vendor — the operating job is EHR connectivity and clinical-moment delivery, with execution layered on through partners.

The January 2026 PulsePoint partnership sharpened that positioning. PulsePoint describes Flora as the EHR connectivity layer enabling programmatic EHR inventory through a connected health-system network, while PulsePoint provides the DSP and broader omnichannel media execution layer. That makes Flora most comparable to point-of-care and HCP activation vendors, with a narrower systems-integration role than full-service marketing agencies.

Healthcare Marketing Comms Capability Model

The framework below standardizes how Rx Almanac evaluates healthcare-marketing-comms capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Flora Health is evaluated as a workflow-native point-of-care channel, not as a full-service marketing agency, a medical-affairs platform, or an outsourced field-deployment vendor - the operating job is EHR connectivity and clinical-moment delivery, with execution layered on through partners.

Capability	Buyer should compare	Flora Health readout
Brand strategy and launch planning	Positioning, segmentation, message architecture, launch sequencing, campaign platform, and brand planning.	Adjacent. Flora focuses on activation and measurement; broader brand strategy typically comes from an agency, PulsePoint, or the manufacturer. Confirm strategic ownership at scope-of-work definition.
HCP media and omnichannel activation	HCP targeting, media, point-of-care, digital, social, congress, rep-triggered, and CRM-connected activation.	Core engagement model. Flora enables workflow-native HCP engagement through EHR and health-system connectivity, with PulsePoint providing programmatic EHR activation.
Payer, access, and market access communications	Payer tools, value messages, reimbursement content, access pull-through, and patient-services communications.	Documented adjacency. Flora links prescribing workflows, EHR environments, and access strategy; confirm whether access support is content, data, workflow integration, or operational services.
Medical/clinical content and MLR operations	Clinical story, claims support, MLR workflows, medical education, scientific accuracy, and compliant content operations.	Not the buyer-facing scope. Flora is not a medical-content or MLR operations vendor; confirm whether medical content lives with an agency, an MSL platform, or in-house.
Measurement, targeting, and optimization	Audience data, campaign analytics, attribution, test-and-learn loops, and performance optimization.	Documented in profile. Flora positions validated data and performance measurement as part of its life-sciences commercial value proposition, with campaign reporting and optimization tied to partner platforms.
Agency integration and execution capacity	Creative, media, PR, medical, access, production, localization, and account-service capacity.	Partner-led. Evaluate Flora as an EHR systems integrator and partner connector, not as the sole agency of record or full execution stack.

Buyer Fit

• Where to use it: Use Flora when a brand needs point-of-care HCP activation inside EHR or health-system workflows, especially when the media plan already includes programmatic HCP channels.
• Therapy and product fit: Best suited to therapies where prescribing context, access friction, and clinical-workflow timing materially affect uptake. Drug-type fit includes small molecule, biologics, and specialty products.
• Commercial fit: Pricing is likely custom/RFP, with scope driven by EHR inventory, partner roles, measurement requirements, access-workflow needs, and compliance guardrails.
• Profile signal: Best-fit buyers include pharma manufacturers, biotech launch teams, health systems, and providers evaluating in-workflow education or access support.
• Reference diligence: Confirm live EHR/health-system reach, who owns media buying and optimization, how access claims are supported, what data is available to the manufacturer, and where Flora stops versus PulsePoint or another activation partner.

Differentiators

• EHR and health-system integration: Flora connects technologies and partner solutions inside existing EHRs and health systems rather than relying only on off-workflow media placements.
• PulsePoint programmatic EHR channel: The 2026 partnership gives PulsePoint exclusive programmatic access to EHR inventory enabled through Flora’s connected health-system network.
• Clinical-moment activation: The value proposition is reaching HCPs during prescribing, chart review, care-plan, or treatment-initiation workflows.
• Access and prescribing-workflow adjacency: Flora ties engagement to access strategy and patient movement from intent to therapy, but buyers should validate how much operational access support is actually included.
• Measurement orientation: Public materials emphasize validated data, engagement strategy, and performance measurement delivered through established platforms and partners.

RFP Questions

• Which EHRs, health systems, and clinical workflows are live for the target specialty and product?
• What inventory is available directly through Flora versus through PulsePoint or another media partner?
• How are targeting, frequency capping, measurement, and reporting governed across EHR and non-EHR channels?
• What access-strategy functions are workflow integrations versus advisory content or campaign messaging?
• What data can flow back to manufacturer, hub, field reimbursement, and agency teams without disrupting clinical workflow or compliance controls?

Recent Activity

• Jan 2026: PulsePoint announced an exclusive EHR programmatic partnership with Flora Health for scalable in-workflow HCP engagement.
• 2025: Flora continued positioning around EHR and health-system integration, including leadership and commercial-expansion activity.
• 2024: EvergreenIQ was launched as a data product for pharmaceutical marketing and engagement intelligence.